New model analyzes CT scans to identify high-risk individuals

Researchers at Case Western Reserve University, University Hospitals and Houston Methodist will harness the power of artificial intelligence (AI) to more accurately predict risk of heart failure and other cardiovascular events, including estimating when an adverse event might occur, by developing an AI model that “learns” from patient scans.

Meta Title: AstraZeneca Plc Patent: Inhibitors of Complement Factor D for Treating Disorders

Share this article According to GlobalData’s company profile on AstraZeneca, Personalized cancer vaccines was a key innovation area identified from patents. AstraZeneca‘s grant share as

April 23, 2024

White House Drug Czar Releases Plan to Combat Xylazine-Laced Fentanyl

The Biden administration released a plan Monday to combat the problem of fentanyl being laced with xylazine, a veterinary tranquilizer implicated in increasing numbers of

July 12, 2023

Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs

Top of the morning to you, and a fine one it is. Cool breezes and clear blue skies are wafting above the Pharmalot campus, where

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.